ProfileGDS4718 / 221103_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 35% 44% 34% 47% 48% 40% 39% 31% 38% 44% 31% 55% 41% 44% 39% 47% 34% 31% 45% 54% 37% 37% 40% 42% 44% 38% 39% 52% 62% 34% 36% 35% 42% 39% 35% 35% 37% 32% 40% 27% 45% 47% 38% 37% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.770535
GSM549102patient 115, normal, homogenized [OPG study]5.1908344
GSM549104patient 119, normal, homogenized [OPG study]4.703334
GSM549108patient 138, normal, homogenized [OPG study]5.3786447
GSM549119patient 077, normal, homogenized [OPG study]5.4293148
GSM549133patient 032, cancer, homogenized [OPG study]4.9519740
GSM549139patient 042, cancer, homogenized [OPG study]4.9323839
GSM549099patient 107, normal, homogenized [OPG study]4.6250631
GSM549109patient 139, normal, homogenized [OPG study]4.9415538
GSM549110patient 046, normal, homogenized [OPG study]5.1842944
GSM549114patient 063, normal, homogenized [OPG study]4.5395631
GSM549122patient 082, normal, homogenized [OPG study]5.7970555
GSM549134patient 033, cancer, homogenized [OPG study]5.0153141
GSM549136patient 036, cancer, homogenized [OPG study]5.1289844
GSM549140patient 044, cancer, homogenized [OPG study]4.908339
GSM549111patient 047, normal, homogenized [OPG study]5.3058147
GSM549113patient 057, normal, homogenized [OPG study]4.6504334
GSM549132patient 031, cancer, homogenized [OPG study]4.5689331
GSM549137patient 038, cancer, homogenized [OPG study]5.2002945
GSM549142patient 047, cancer, homogenized [OPG study]5.8665954
GSM549100patient 110, normal, homogenized [OPG study]4.8776537
GSM549107patient 135, normal, homogenized [OPG study]4.8177137
GSM549115patient 068, normal, homogenized [OPG study]4.940840
GSM549116patient 072, normal, homogenized [OPG study]5.0525842
GSM549120patient 078, normal, homogenized [OPG study]5.2053344
GSM549131patient 030, cancer, homogenized [OPG study]4.8471738
GSM549118patient 074, normal, homogenized [OPG study]4.9436439
GSM549129patient 027, cancer, homogenized [OPG study]5.6260952
GSM549123patient 088, normal, homogenized [OPG study]6.2660262
GSM549124patient 006, cancer, homogenized [OPG study]4.763934
GSM549126patient 015, cancer, homogenized [OPG study]4.7847136
GSM549128patient 025, cancer, homogenized [OPG study]4.7260335
GSM549103patient 117, normal, homogenized [OPG study]5.1372242
GSM549117patient 073, normal, homogenized [OPG study]4.9110639
GSM549138patient 041, cancer, homogenized [OPG study]4.7402535
GSM549141patient 045, cancer, homogenized [OPG study]4.6844435
GSM549130patient 028, cancer, homogenized [OPG study]4.8460637
GSM549101patient 111, normal, homogenized [OPG study]4.6576432
GSM549105patient 128, normal, homogenized [OPG study]4.9996440
GSM549106patient 134, normal, homogenized [OPG study]4.3850927
GSM549112patient 048, normal, homogenized [OPG study]5.2435945
GSM549125patient 011, cancer, homogenized [OPG study]5.3426247
GSM549127patient 024, cancer, homogenized [OPG study]4.9009138
GSM549135patient 035, cancer, homogenized [OPG study]4.8053737